Leitlinienempfehlungen und Qualitätsindikatoren bei der invasiven Versorgung der peripheren arteriellen Verschlusskrankheit in Deutschland

Standard

Harvard

APA

Vancouver

Bibtex

@article{590b34f89e9b45c09b99992e060a939d,
title = "Leitlinienempfehlungen und Qualit{\"a}tsindikatoren bei der invasiven Versorgung der peripheren arteriellen Verschlusskrankheit in Deutschland: IDOMENEO-Studie als Beitrag zur Qualit{\"a}tsentwicklung und Versorgungsforschung in der Gef{\"a}{\ss}medizin",
abstract = "Due to the paucity of independent trials, practical guidelines for the diagnosis and treatment of peripheral arterial disease (PAD) contain several recommendations developed by expert consensus. Furthermore, there is a lack of commonly defined quality indicators and valid data on real world treatment. Therefore, it remains challenging to scrutinize if treatment reality is conforming to guideline recommendations. This article aims to give a short overview on existing guideline recommendations. It further aims to introduce the multistage multimethodological IDOMENEO study, utilizing primary registry data (GermanVasc) and health insurance claims data (BARMER) in PAD treatment.",
keywords = "English Abstract, Journal Article, Review, Biomedical Research/standards, Cardiology/standards, Combined Modality Therapy/standards, Extremities/blood supply, Germany, Humans, Ischemia/diagnosis, Peripheral Arterial Disease/diagnosis, Quality Improvement/standards, Quality Indicators, Health Care/standards, Risk Factors",
author = "Christian-Alexander Behrendt and Henrik Rie{\ss} and Martin H{\"a}rter and Levente Kriston and Hannes Federrath and Ursula Marschall and Debus, {Eike Sebastian}",
year = "2018",
month = feb,
doi = "10.1007/s00103-017-2676-9",
language = "Deutsch",
volume = "61",
pages = "218--223",
journal = "BUNDESGESUNDHEITSBLA",
issn = "1436-9990",
publisher = "Springer",
number = "2",

}

RIS

TY - JOUR

T1 - Leitlinienempfehlungen und Qualitätsindikatoren bei der invasiven Versorgung der peripheren arteriellen Verschlusskrankheit in Deutschland

T2 - IDOMENEO-Studie als Beitrag zur Qualitätsentwicklung und Versorgungsforschung in der Gefäßmedizin

AU - Behrendt, Christian-Alexander

AU - Rieß, Henrik

AU - Härter, Martin

AU - Kriston, Levente

AU - Federrath, Hannes

AU - Marschall, Ursula

AU - Debus, Eike Sebastian

PY - 2018/2

Y1 - 2018/2

N2 - Due to the paucity of independent trials, practical guidelines for the diagnosis and treatment of peripheral arterial disease (PAD) contain several recommendations developed by expert consensus. Furthermore, there is a lack of commonly defined quality indicators and valid data on real world treatment. Therefore, it remains challenging to scrutinize if treatment reality is conforming to guideline recommendations. This article aims to give a short overview on existing guideline recommendations. It further aims to introduce the multistage multimethodological IDOMENEO study, utilizing primary registry data (GermanVasc) and health insurance claims data (BARMER) in PAD treatment.

AB - Due to the paucity of independent trials, practical guidelines for the diagnosis and treatment of peripheral arterial disease (PAD) contain several recommendations developed by expert consensus. Furthermore, there is a lack of commonly defined quality indicators and valid data on real world treatment. Therefore, it remains challenging to scrutinize if treatment reality is conforming to guideline recommendations. This article aims to give a short overview on existing guideline recommendations. It further aims to introduce the multistage multimethodological IDOMENEO study, utilizing primary registry data (GermanVasc) and health insurance claims data (BARMER) in PAD treatment.

KW - English Abstract

KW - Journal Article

KW - Review

KW - Biomedical Research/standards

KW - Cardiology/standards

KW - Combined Modality Therapy/standards

KW - Extremities/blood supply

KW - Germany

KW - Humans

KW - Ischemia/diagnosis

KW - Peripheral Arterial Disease/diagnosis

KW - Quality Improvement/standards

KW - Quality Indicators, Health Care/standards

KW - Risk Factors

U2 - 10.1007/s00103-017-2676-9

DO - 10.1007/s00103-017-2676-9

M3 - SCORING: Review

C2 - 29230514

VL - 61

SP - 218

EP - 223

JO - BUNDESGESUNDHEITSBLA

JF - BUNDESGESUNDHEITSBLA

SN - 1436-9990

IS - 2

ER -